Challenges of Treating Acute Coronary Syndrome

Published Online: Monday, March 25, 2013
Follow Pharmacy_Times:
In this video, from AJMCtv, Peter Berger, MD, FACC, FAHA, chairman of cardiology and co-director of the Geisinger Heart & Vascular Institute and director of the Cardiovascular Center for Clinical Research at Geisinger Clinic in Danville, Pennsylvania, discusses the challenge of individualizing antiplatelet treatment for acute coronary syndrome (ACS) patients.

Related Articles
Studies have reported that up to half of patients discontinue prescribed therapies soon after hospital discharge.
FDA officials have recommended approval for Amgen’s proposed cholesterol-lowering medication, evolocumab (Repatha).
Pharmacists know changes in vitamin K intake can drastically alter INR values in patients taking warfarin.
Acute coronary syndrome is clearly a problem in the elderly population, especially since survival declines with increasing age.
Latest Issues
$auto_registration$